Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns
by Contributor since / Followers
1 day ago
angelp
Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and COVID-19 cases in the U.S. following the latest respiratory illness data announced by the CDC last week.
